Reunion Neuroscience

      Biotech research pioneer treating mental health conditions through the development of novel psychedelic compounds.

      Canada
      Startup

      Reunion Neuroscience is committed to innovating therapeutic solutions to treat mental health conditions through the development of novel psychedelic compounds. NASDAQ:REUN

      • Femtech Canada

        Femtech Canada

        Get connected with the best and brightest in Canadian Femtech.

        Accelerator
      Greg Mayes

      Greg Mayes

      • President & Chief Executive Officer
      Nathan Bryson

      Nathan Bryson

      • Chief Scientific Officer (CSO)
      Mark Theeuwes

      Mark Theeuwes

      • Chief Operating Officer (COO)
      Reunion Neuroscience